Gastrin suppresses growth of CCK2 receptor expressing colon cancer cells by inducing apoptosis in vitro and in vivo

Gastroenterology

Volumn 129, Issue 3, 2005, Pages 952-968

  Müerköster, Susanne ^a   Isberner, Anett ^a   Arlt, Alexander ^a   Witt, Maike ^a   Reimann, Babette ^a   Blaszczuk, Ewelina ^a   Werbing, Veronika ^a   Fölsch, Ulrich R ^a   Schmitz, Frank ^b   Schäfer, Heiner ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b ST JOSEF HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; CHOLECYSTOKININ B RECEPTOR; GASTRIN 17; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOCORTIN 5; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; OMEPRAZOLE; TRANSCRIPTION FACTOR AP 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL COUNT; CELL CYCLE; CELL CYCLE G2 PHASE; CELL GROWTH; CELL PROLIFERATION; COLON CARCINOMA; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPERGASTRINEMIA; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; MITOSIS INHIBITION; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCID MOUSE; SIGNAL TRANSDUCTION; STAINING; SYSTEMIC DISEASE; WESTERN BLOTTING; WILD TYPE;

EID: 24144455998     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2005.06.059     Document Type: Article

References (51)

1. G.J. Dockray, A. Varro, R. Dimaline Gastric endocrine cells gene expression, processing and targeting of the active products Physiol Rev 76 1996 767 798
2. E. Rozengurt, J.H. Walsh Gastrin, CCK, signaling, and cancer Annu Rev Physiol 63 2001 49 76
3. G.S. Baldwin, A. Shulkes Gastrin, gastrin receptors and colorectal carcinoma Gut 42 1998 581 584
4. G.S. Baldwin Binding of progastrin fragments to the 78 kDa gastrin binding protein FEBS Lett 359 1995 97 100
5. F. Hollande, A. Imdahl, T. Mantamadiotis, G.D. Ciccotosto, A. Shulkes, G.S. Baldwin Glycine-extended gastrin acts as an autocrine growth factor in nontransformed colon cell line Gastroenterology 113 1997 1576 1588
6. 1-80 stimulates growth of intestinal epithelial cells in vitro via high-affinity binding sites Am J Physiol Gastrointest Liver Physiol 284 2003 G328 G339
7. T.J. Koh, J.K. Field, A. Varro, T. Liloglou, P. Fielding, G. Cui, J.M. Houghton, G.J. Dockray, T.C. Wang Glycine-extended gastrin promotes the growth of lung cancer Cancer Res 64 2004 196 201
8. V.M. Stephan, M. Sawada, A. Todisco, C.J. Dickinson Glycine-extended gastrin exerts growth-promoting effects on human colon cancer cells Mol Med 5 1999 147 159
9. T.J. Koh, G.J. Dockray, A. Varro, R.J. Cahill, C.A. Dangler, J.G. Fox, T.C. Wang Over expression of glycine-extended gastrin in transgenic mice results in increased colonic proliferation J Clin Invest 103 1999 1119 1126
10. S.A. Watson, D. Michaeli, S. Grimes, T.M. Morris, G. Robinson, A. Varro, T.A. Justin, J.D. Hardcastle Gastrimmune raises antibodies that neutralize amidated and glycine-extended gastrin-17 and inhibit growth of colon cancer Cancer Res 56 1996 880 885
11. S. Kermorgant, T. Lehy Glycine-extended gastrin promotes the invasiveness of human colon cancer cells Biochem Biophys Res Commun 285 2001 136 141
12. M. Baba, K. Itoh, M. Tatsuta Glycine-extended gastrin induces matrix-metalloproteinase-1- and -3-mediated invasion of human colon cancer cells through type 1 collagen gel and Matrigel Int J Cancer 111 2004 23 31
13. A. Aly, A. Shulkes, G.S. Baldwin Gastrins, cholecystokinins and gastrointestinal cancer Biochem Biophys Acta 1704 2004 1 10
14. 1-80 reduces apoptosis of intestinal epithelial cells and up-regulates cytochrome c oxidase Vb levels and synthesis of ATP Am J Physiol Gastrointest Liver Physiol 285 2003 G1097 G1110
15. R.K. Siddheshwar, J.C. Gray, S.B. Kelly Plasma levels of progastrin but not amidated gastrin or glycine extended gastrin are elevated in patients with colorectal carcinoma Gut 48 2001 47 52
16. A. Nagata, I. Mitsuhiro, I. Nobuko, K. Junko, T. Hiroshi, O. Minowa, C. Kazuo, M. Toshimitsu, N. Tetsuo G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo Proc Natl Acad Sci U S A 93 1996 11825 11830
17. D.H. Song, B. Rana, J.R. Wolfe, G. Crimmins, C. Choi, C. Albanese, T.C. Wang, R.G. Pestell, M.M. Wolfe Gastrin-induced gastric adenocarcinoma growth is mediated through cyclin D1 Am J Physiol Gastrointest Liver Physiol 285 2003 G217 G222
18. A. Pradeep, C. Sharma, P. Sathyanarayana, C. Albanese, J.V. Fleming, T.C. Wang, M.M. Wolfe, K.M. Baker, R.G. Pestell, B. Rana Gastrin-mediated activation of cyclin D1 transcription involves β-catenin and CREB pathways in gastric cancer cells Oncogene 23 2004 3689 3699
19. I. Rooman, J. Lardon, D. Flamez, F. Schuit, L. Bouwens Mitogenic effect of gastrin and expression of gastrin receptors in duct-like cells of rat pancreas Gastroenterology 121 2001 940 949
20. C.M. Thorburn, G.D. Friedman, C.J. Dickinson, J.H. Vogelman, N. Orentreich, J. Parsonnet Gastrin and colorectal cancer a prospective study Gastroenterology 115 1998 275 280
21. Min-/+ mouse model of familial adenomatous polyposis Cancer Res 61 2001 625 631
22. J.C. Harris, P.A. Clarke, A. Awan, J. Jankowski, S.A. Watson An antiapoptotic role for gastrin and the gastrin/CCK-2 receptor in Barrett's esophagus Cancer Res 64 2004 1915 1919
23. S. Ramamoorthy, V. Stepan, A. Todisco Intracellular mechanisms mediating the anti-apoptotic action of gastin Biochem Biophys Res Commun 323 2004 44 48
24. P. Singh, M. Velasco, R. Given, M. Wargovich, A. Varro, T.C. Wang Mice overexpressing progastrin are predisposed for developing abberrant colonic crypt foci in response to AOM Am J Physiol Gastrointest Liver Physiol 278 2000 G390 G399
25. S. Cobb, T. Wodd, L. Tessarollo, M. Velasco, R. Given, A. Varro, N. Tarasova, P. Singh Deletion of functional gastrin gene markedly increases colon carcinogenesis in response to azoxymethane in mice Gastroenterology 123 2002 516 530
26. D.M. Pinson, N. Havu, M.I. Sztern, H. Mattsson, G.A. Looney, B.F. Kimler, A. Hurwitz Drug-induced hypergastrinemia absence of trophic effects on colonic carcinoma in rats Gastroenterology 108 1995 1068 1074
27. A. Tocchi, G. Mazzoni, F. Puma, M. Miccini, G. Daddi, E. Bettelli, D. Cassini, S. Brozetti Clinical significance of serum gastrin levels in patients with colorectal cancer Int J Biol Markers 19 2004 46 51
28. F. Lefranc, N. Sadeghi, T. Metens, J. Brotchi, I. Salmon, R. Kiss Characterization of gastrin-induced cytostatic effect on cell proliferation in experimental malignant gliomas Neurosurgery 52 2003 881 890
29. N. Kanno, S. Glaser, U. Chowdhury, J.L. Phinizy, L. Baiocchi, H. Francis, G. LeSage, G. Alpini Gastrin inhibits cholongiocarcinoma growth via increased apoptosis by activation of Ca2+-dependent protein kinase C-α J Hepatol 34 2001 284 291
30. M. Konopleva, E. Elstner, T.J. McQueen, T. Tsao, A. Sudarikov, W. Hu, W.D. Schober, R.Y. Wang, D. Chism, S.M. Kornblau, A. Younes, S.J. Collins, H.P. Koeffler, M. Andreeff Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias Mol Cancer Ther 10 2004 1249 1262
31. T. Takadera, Y. Shiraishi, T. Ohyashiki Prostaglandin E2 induced caspase-dependent apoptosis possibly through activation of EP2 receptors in cultured hippocampal neurons Neurochem Int 45 2004 713 719
32. W. Rengifo-Cam, P. Singh Role of progastrins and gastrins and their receptors in GI and pancreatic cancer targets for treatment Curr Pharm Des 10 2004 2345 2358
33. F. Schmitz, J.-M. Otte, H.U. Stechele, B. Reimann, T. Banasiewicz, U.R. Fölsch, W.E. Schmidt, K.-H. Herzig CCK-B/gastrin receptors in human colorectal cancer Eur J Clin Invest 31 2001 812 820
34. H. Schäfer, A. Arlt, A. Trauzold, A. Hünermann-Jansen, W.E. Schmidt The putative apoptosis inhibitor IEX-1L is a mutant nonspliced variant of p22(PRG1/IEX-1) and is not expressed in vivo Biochem Biophys Res Commun 262 1999 139 145
35. S. Müerköster, A. Arlt, M. Witt, A. Gehrz, S. Haye, C. March, F. Grohmann, K. Wegehenkel, H. Kalthoff, U.R. Fölsch, H. Schäfer Usage of the NF-κB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancer Int J Cancer 104 2003 469 476
36. H. Schäfer, J. Zheng, F. Gundlach, R. Günther, E.G. Siegel, U.R. Fölsch, W.E. Schmidt Pituitary adenylate-cyclase-activating polypeptide stimulates proto-oncogene expression and activates the AP-1 (c-Fos/c-Jun) transcription factor in AR4-2J pancreatic carcinoma cells Eur J Biochem 242 1996 467 476
37. H. Schäfer, J. Diebel, A. Arlt, A. Trauzold, W.E. Schmidt The promoter of human p22/PACAP response gene 1 (PRG1) contains functional binding sites for the p53 tumor suppressor and for NF-κB FEBS Lett 436 1998 139 143
38. T.C. Wang, T.J. Koh, A. Varro, R.J. Cahill, C.A. Dangler, J.G. Fox, G.J. Dockray Processing and proliferative effects of human progastrin in transgenic mice J Clin Invest 98 1996 1918 1929
39. T.J. Koh, J.R. Goldenring, S. Ito, H. Mashimo, A.S. Kopin, A. Varro, G.J. Dockray, T.C. Wang Gastrin deficiency results in altered gastric differentiation an decreased colonic proliferation in mice Gastroenterology 113 1997 1015 1025
40. C.M. Thumwood, J. Hong, G.S. Baldwin Inhibition of cell proliferation by the cholecystokinin antagonist L-364-718 Exp Cell Res 192 1991 189 192
41. H.-J. Monstein, K. Fransén, J. Dimberg, P. Söderkvist K-ras and B-raf gene mutations are not associated with gastrin- and CCK2 receptor mRNA expression in human colorectal tumour tissues Eur J Clin Invest 34 2004 100 106
42. A.J. FitzGerald, M.A. Ghatei, N. Mandir, S.R. Bloom, L. Iversen, R.A. Goodlad Effects of amidated gastrin and glycine-extended gastrin on cell proliferation and crypt fission in parenterally and orally fed rats Digestion 66 2002 58 66
43. K. Detjen, D. Yule, M.-J. Tseng, J.A. Williams, C.D. Logsdon CCK-B receptors produce similar signals but have opposite growth effects on CHO cells and Swiss 3T3 cells Am J Physiol 273 1997 C1449 C1457
44. K. Detjen, M. Fenrich, C.D. Logsdon Transfected CCKA and CCKB receptors mediate growth inhibitory effects on human pancreatic cancer cell lines Gastroenterology 112 1997 952 959
45. H. Sawai, T. Okazaki, H. Yamamoto, H. Okano, Y. Takeda, M. Tashima, H. Sawada, M. Okuma, H. Ishikura, H. Umehara Requirement of AP-1 for ceramide-induced apoptosis in human leukemia HL-60 cells J Biol Chem 270 1995 27326 27331
46. R. Eferl, E.F. Wagner AP-1 a double-edged sword in tumorigenesis Nat Rev Cancer 3 2003 859 868
47. E. Shaulian, M. Karin AP-1 in cell proliferation and survival Oncogene 20 2001 2390 2400
48. 3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3β and NF-κB Oncogene 23 2004 2465 2471
49. P.Y. Yeh, K.H. Yeh, S.E. Chuang, Y.C. Song, A.L. Cheng Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-κB activation by protein phosphatase 4-mediated NF-κB p65 Thr dephosphorylation J Biol Chem 279 2004 26143 26148
50. M. Ogasa, Y. Miyazaki, S. Hiraoka, S. Kitamura, Y. Nagasawa, O. Kishida, T. Miyazaki, T. Kiyohara, Y. Shinomura, Y. Matsuzawa Gastrin activates nuclear factor-κB (NF-κB) through a protein kinase C dependent pathway involving NF-κB inducing kinase, inhibitor κB (IκB) kinase, and tumour necrosis factor receptor associated factor 6 (TRAF6) in MKN-28 cells transfected with gastrin receptor Gut 52 2003 813 819
51. S. Hiraoka, Y. Miyazaki, S. Kitamura, M. Toyota, T. Kiyohara, Y. Shinomura, N. Mukaida, Y. Matsuzawa Gastrin induces CXC chemokine expression in gastric epithelial cells through activation of NF-κB Am J Physiol Gastrointest Liver Physiol 281 2001 G735 G742